GlassScriptPhysician profile
Pamela Asghar
NPI 1174519136
$11,105.11
in general payments reported to CMS, 2019-2025
25 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $534 · 2021: $535 · 2022: $8,867 · 2023: $382 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,437.77 | 2022-2025 | Da Vinci Surgical System |
| Millicent US INC | $350.14 | 2019-2023 | Intrarosa |
| Abbvie INC. | $342.00 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $318.30 | 2020-2022 | |
| Lupin INC. | $251.08 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $184.40 | 2022-2023 | |
| Aspira Women'S Health INC | $151.56 | 2019-2023 | Ova1 |
| Therapeuticsmd, INC. | $133.04 | 2019-2021 | |
| Exact Sciences Corporation | $131.18 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $127.71 | 2019-2023 | |
| Scynexis, INC. | $120.26 | 2022 | |
| Amag Pharmaceuticals, INC. | $92.73 | 2019 | |
| Evofem Biosciences, INC. | $88.93 | 2021-2022 | |
| Exeltis, USA INC. | $73.05 | 2019-2025 | Slynd |
| Agile Therapeutics, INC. | $52.00 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $47.33 | 2025 | |
| Medtronic, INC. | $33.97 | 2025 | Venaseal |
| Organon LLC | $26.29 | 2022 | |
| Avion Pharmaceuticals | $23.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.38 | 2025 | |
| Sumitomo Pharma America, INC. | $22.22 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $21.41 | 2021 | |
| Astellas Pharma US INC | $20.12 | 2025 | Veozah |
| Coopersurgical, INC. | $17.09 | 2022 | |
| Allergan, INC. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Asghar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.